Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.
AUTOR(ES)
Ariniego, R
RESUMO
The haemodynamic effects of a new beta 1-receptor agonist, 1-(4 hydroxyphenoxy) 3-isopropylamino-2-propanol, were studied in 25 patients after acute myocardial infarction using non-invasive methods. The drug caused an increase in systolic blood pressure and pulse pressure, without change in diastolic blood pressure, and a slight increase in heart rate and reduction in the pre-ejection period. These changes were greater in patients without a history of left heart failure. It is suggested that this cardioselective drug possesses positive inotropic activity but only slight positive chronotropic activity. The substance has been further investigated as a possible antidote to unwanted cardiac side effects of the cardioselective beta-blocker, metoprolol. The changes in the cardiovascular dynamics caused by metoprolol in patients with acute myocardial infarction were promptly reversed by this new beta 1-agonist. With its positive inotropic properties and its efficacy in reversing the effects of a cardioselective beta-blocker, the drug is a potentially useful pharmacological agent to support an acutely depressed myocardium in patients on beta-blocking agents.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=482127Documentos Relacionados
- Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A).
- Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent.
- Metipranolol. Pharmacology of Beta-blocking Agents and Use of Metipranolol in Ophthalmology
- Haemodynamic effects of isoprenaline in acute myocardial infarction.
- Haemodynamic effects of selective beta-adrenergic blockade during acute stage of myocardial infarction.